NEVVI Medicare utilization intelligence

← back

MOON, CHARLESMD NPI 1487712295 Clinician

Dermatology · CAPE GIRARDEAU, MO

Specialty Dermatology — from billed Medicare claims
Trained UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 27 years since medical school (class of 1999, self-reported to CMS)
Location CAPE GIRARDEAU, MO · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 67 codes billed · 33,889 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ADVANCED DERMATOLOGY OF SOUTHEAST MISSOURI PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2017-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
J3245 Injection, tildrakizumab, 1 mg
88305 Pathology examination of tissue using a microscope, intermediate complexity
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11102 Biopsy of related skin growth, first growth
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
17110 Destruction of skin growth, 1-14 growths
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
11103 Biopsy of related skin growth, each additional growth
88342 Special stained specimen slides to examine tissue, initial procedure
88341 Special stained specimen slides to examine tissue, each additional procedure
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
88312 Special stained specimen slides to identify organisms including interpretation and report
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
17004 Destruction of precancer skin growth, 15 or more growths
69100 Biopsy of ear
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
13152 Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm
14041 Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm
14060 Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less
96574 Application of light with debridement to destroy precancer skin growth
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
13151 Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11900 Injection into skin growth, 1-7 growths
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm
14040 Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less
14061 Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm
11200 Removal of skin tag, 1-15 skin tags
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
17314 Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
88304 Pathology examination of tissue using a microscope, moderately low complexity
10060 Simple or single drainage of skin abscess
11104 Punch biopsy, first skin growth
96573 Application of light by qualified health care professional to destroy precancer skin growth
15260 Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
10040 Acne surgery
97597 Removal of tissue from wound, 20.0 sq cm or less
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
13131 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm
87220 Tissue fungi or parasites
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
13122 Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
Q0112 All potassium hydroxide (koh) preparations
11403 Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.